Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.271
Sell
RSI(14)
44.852
Neutral
STOCH(KDJ)(9,3,3)
26.920
Neutral
ATR(14)
1.374
Low Volatility
CCI(14)
-171.847
Sell
Williams %R
71.914
Sell
TRIX(12,20)
-0.006
Sell
StochRSI(14)
34.365
Buy
GE Healthcare Technologies Inc
GEHC72.800USD
+0.420+0.58%
Market hours （ET）Quotes delayed by 15 min
33.24BMarket Cap
14.83P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Currency: USD Updated：2025-09-03Key Insights
The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
21
analysts
Buy
Current Rating
87.009
Target Price
+21.52%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
Fairly Valued
The company’s latest is 14.75, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 369.63M shares, decreasing 13.59% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 51.90M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.10.
Financial Health
Currency: USD Updated：2025-09-03The company's current financial score is 7.94, which is higher than the Healthcare Services & Equipment industry's average of 7.15. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 4.78B, representing a year-over-year increase of 2.73%, while its net profit experienced a year-over-year increase of 50.80%.
Score
Financials
7.80
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data
Quality of Earnings
7.00
Operational Efficiency
7.65
Growth Potential
8.08
Shareholder Returns
9.17
Company Valuation
Currency: USD Updated：2025-09-03The company’s current valuation score is 1.80, which is lower than the Healthcare Services & Equipment industry's average of 2.15. Its current P/E ratio is 15.13, which is 0.67% below the recent high of 15.23 and 3.51% above the recent low of 14.60.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 72/280
No Data
Earnings Forecast
Currency: USD Updated：2025-09-03The company’s current earnings forecast score is 8.10, which is higher than the Healthcare Services & Equipment industry's average of 7.66. The average price target for GE Healthcare Technologies Inc is 88.00, with a high of 106.00 and a low of 73.00.
Score
Support & Resistance
No Data
Analyst Rating
Based on
21
analysts
Buy
Current Rating
87.009
Target Price
+21.52%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
93
Total
4
Median
7
Average
Company name
Ratings
Analysts
GE Healthcare Technologies Inc
GEHC
21
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
34
Veeva Systems Inc
VEEV
32
Thermo Fisher Scientific Inc
TMO
31
1
2
3
...
19
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
No Data
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated：2025-09-03The company’s current price momentum score is 8.76, which is higher than the Healthcare Services & Equipment industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 76.85 and the support level at 70.38, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
73.138
Sell
MA10
73.661
Sell
MA20
73.330
Sell
MA50
74.163
Sell
MA100
71.799
Buy
MA200
77.481
Sell
Institutional Confidence
Currency: USD Updated：2025-09-03The company’s current institutional recognition score is 7.00, which is lower than the Healthcare Services & Equipment industry's average of 7.19. The latest institutional shareholding proportion is 80.96%, representing a quarter-over-quarter decrease of 7.50%. The largest institutional shareholder is The Vanguard, holding a total of 51.90M shares, representing 11.37% of shares outstanding, with 0.76% decrease in holdings.
Score
Institutional Shareholding
No Data
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
Capital Research Global Investors
State Street Global Advisors (US)
Geode Capital Management, L.L.C.
Invesco Capital Management (QQQ Trust)
Citadel Advisors LLC
1
2
Risk Assessment
Currency: USD Updated：2025-09-03The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
--
VaR
--
240-Day Maximum Drawdown
+37.40%
240-Day Volatility
+36.27%
Return
Best Daily Return
60 days
+3.14%
120 days
+10.60%
5 years
--
Worst Daily Return
60 days
-7.82%
120 days
-15.96%
5 years
--
Sharpe Ratio
60 days
+0.31
120 days
-0.58
5 years
--
Risk Assessment
Maximum Drawdown
240 days
+37.40%
3 years
--
5 years
--
Return-to-Drawdown Ratio
240 days
-0.44
3 years
--
5 years
--
Skewness
240 days
-1.15
3 years
--
5 years
--
Volatility
Realised Volatility
240 days
+36.27%
5 years
--
Standardised True Range
240 days
+2.85%
5 years
--
Downside Risk-Adjusted Return
120 days
-63.23%
240 days
-63.23%
Maximum Daily Upside Volatility
60 days
+21.13%
Maximum Daily Downside Volatility
60 days
+22.75%
Liquidity
Average Turnover Rate
60 days
+0.80%
120 days
+0.95%
5 years
--
Turnover Deviation
20 days
-9.82%
60 days
+10.40%
120 days
+30.75%
Peer Comparison
Currency: USD Updated：2025-09-03GE Healthcare Technologies Inc
GEHC
6.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Insulet Corp
PODD
7.90 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Merit Medical Systems Inc
MMSI
7.75 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brightspring Health Services Inc
BTSG
7.67 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tenet Healthcare Corp
THC
7.67 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
COR
7.60 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.
